![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 249/12 | (2006.01) |
A61K 31/138 | (2006.01) | ||
A61K 31/15 | (2006.01) | ||
A61K 31/4196 | (2006.01) | ||
A61K 31/4525 | (2006.01) | ||
A61K 31/551 | (2006.01) | ||
A61K 31/5513 | (2006.01) | ||
A61K 45/00 | (2006.01) | ||
A61P 1/00 | (2006.01) | ||
A61P 25/18 | (2006.01) | ||
A61P 25/22 | (2006.01) | ||
A61P 25/24 | (2006.01) | ||
A61P 25/30 | (2006.01) | ||
A61P 31/10 | (2006.01) | ||
C07D 495/04 | (2006.01) |
(11) | Number of the document | 1135136 |
(13) | Kind of document | T |
(96) | European patent application number | 99961750.9 |
Date of filing the European patent application | 1999-11-22 | |
(97) | Date of publication of the European application | 2001-09-26 |
(45) | Date of publication and mention of the grant of the patent | 2003-11-05 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US9927/644 |
Date | 1999-11-22 |
(87) | Number | WO 0003/0649 |
Date | 2000-06-02 |
(30) | Number | Date | Country code |
109551 P | 1998-11-23 | US |
(72) |
YELLE, William, E., US
|
(73) |
Sepracor Inc.,
111 Locke Drive, Marlborough, MA 01752,
US
|
(54) | PHARMACEUTICAL COMPOSITIONS CONTAINING OLANZAPINE-N-OXIDE |
PHARMACEUTICAL COMPOSITIONS CONTAINING OLANZAPINE-N-OXIDE |